Ridgeback Capital Investments L.P. 13D and 13G filings for Bicycle Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:08 pm Sale |
2023-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 844,235 2.200% |
-1,420,566 (-62.72%) |
Filing |
| 2023-02-14 4:06 pm Unchanged |
2022-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 2,264,801 7.600% |
0 (Unchanged) |
Filing |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 2,264,801 7.600% |
100,000 (+4.62%) |
Filing |
| 2022-02-14 4:13 pm Purchase |
2021-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 2,164,801 7.400% |
302,968 (+16.27%) |
Filing |
| 2021-02-16 4:17 pm Purchase |
2020-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 1,861,833 8.700% |
717,200 (+62.66%) |
Filing |
| 2020-07-13 4:28 pm Purchase |
2020-07-02 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 1,144,633 6.300% |
1,144,633 (New Position) |
Filing |